AcuFocus - The Intracorneal Company
Leading the World in Ocular Implant Development
AcuFocus, Inc., a privately held company located in Irvine, California is developing the KAMRA™ inlay for the treatment of presbyopia. The KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. By applying the "depth-of-focus"; principle commonly used in photography, the KAMRA inlay controls light transmission allowing only central rays to reach the retina through a fixed 1.6 mm aperture. This outpatient procedure is completed by implanting the cornea inlay under a LASIK-type flap or in a corneal pocket. Patients who have undergone this procedure are once again seeing numbers on a mobile device, reading text messages, and checking the time on a wristwatch with ease.
The KAMRA inlay received CE mark for use in the European Union in 2005 and is an investigational device under IDE (Investigational Device Exemption) in the United States. The device provides a revolutionary treatment option for near vision loss, or presbyopia, which affects 1.5 billion people worldwide.
With over 1,000 participants in worldwide clinical trials and nearly a decade of research and development, the KAMRA inlay is proven to:
- Offer natural vision after 40
- Restore everyday near and intermediate vision and reduce dependency on reading glasses.
- Maintain distance vision.
- The KAMRA inlay is an excellent option for all presbyopes regardless of whether they are nearsighted, farsighted, or have had prior surgery such as LASIK or cataract removal.
AcuFocus owns or has exclusive worldwide license to more than 30 issued United States patents. An additional 50 U.S. and foreign patent applications are now pending.
This broad portfolio covers the design and critical features of the KAMRA inlay plus, extensions of the AcuFocus small-aperture technology beyond the corneal space into the intraocular lens arena. These patents also cover corneal modification, corneal lenses, corneal pocket creation, surgical methods and methods of manufacturing.
Looking into the future, AcuFocus is actively developing additional products. Some are adjuncts to the KAMRA inlay. Others capitalize on the AcuFocus patent portfolio, small-aperture technology or manufacturing technology developed for the inlay.
Contact us today if you are interested in becoming a KAMRA inlay surgeon.
CAUTION The KAMRA™ Inlay is an investigational device, limited by federal (U.S.) law to investigational use and not available for sale in the United States.